title: Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation.
authors.affiliation: Southampton Health Technology Assessments Centre, Wessex Institute for Health Research and Development, University of Southampton, UK.
authors.forename: J
authors.initials: J
authors.lastname: Bryant
authors.forename: E
authors.initials: E
authors.lastname: Loveman
authors.forename: D
authors.initials: D
authors.lastname: Chase
authors.forename: B
authors.initials: B
authors.lastname: Mihaylova
authors.forename: C
authors.initials: C
authors.lastname: Cave
authors.forename: K
authors.initials: K
authors.lastname: Gerard
authors.forename: R
authors.initials: R
authors.lastname: Milne
mesh_terms: D000328:Adult; D003362:Cost-Benefit Analysis; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology / Q000523:psychology; D013006:Growth Hormone / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D013006:Growth Hormone